Human carbonyl reduction pathways and a strategy for their study in vitro.
about
Pharmacogenetics of human carbonyl reductase 1 (CBR1) in livers from black and white donorsA functional genetic polymorphism on human carbonyl reductase 1 (CBR1 V88I) impacts on catalytic activity and NADPH binding affinityInhibition of carbonyl reductase activity in pig heart by alkyl phenyl ketonesBupropion metabolism by human placenta.Interindividual variability in the cardiac expression of anthracycline reductases in donors with and without Down syndrome.Higher activity of polymorphic NAD(P)H:quinone oxidoreductase in liver cytosols from blacks compared to whites.Carbonyl reductases and pluripotent hydroxysteroid dehydrogenases of the short-chain dehydrogenase/reductase superfamily.RNA Sequencing Quantification of Xenobiotic-Processing Genes in Various Sections of the Intestine in Comparison to the Liver of Male Mice.Human microsomal carbonyl reducing enzymes in the metabolism of xenobiotics: well-known and promising members of the SDR superfamily.Carbonyl reduction pathways in drug metabolism.The "Goldilocks Zone" from a redox perspective-Adaptive vs. deleterious responses to oxidative stress in striated muscle.The role of carbonyl reductase 1 in drug discovery and development.Species differences in hepatic biotransformation of the anthelmintic drug flubendazole.Identification of the promoter of human carbonyl reductase 3 (CBR3) and impact of common promoter polymorphisms on hepatic CBR3 mRNA expression.Metabolism of F18, a Derivative of Calanolide A, in Human Liver Microsomes and Cytosol.Carbonyl reductase 1 as a novel target of (-)-epigallocatechin gallate against hepatocellular carcinoma.Efficient isolation of carbonyl-reducing enzymes using affinity approach with anticancer drug oracin as a specific ligand.Effects of Sublethal Exposure to a Glyphosate-Based Herbicide Formulation on Metabolic Activities of Different Xenobiotic-Metabolizing Enzymes in Rats.The aldo-keto reductase superfamily and its role in drug metabolism and detoxification
P2860
Q24646186-BC073588-B42E-4AE5-9898-9244D4EA0BD2Q24647984-856E7712-AFEA-4082-A59F-6B44B5B79BAAQ28293884-6ADE21D3-75D4-425D-BAEB-9352263473FCQ33759322-87AD143A-5CF9-47BF-8B0C-3D1BDDD9F590Q33784640-062A9E36-235E-4009-A426-489D12FBD14BQ35987014-FC200329-2D60-4A8F-94F0-B6E58BA4AA9AQ36761677-D3A59207-9391-4C30-AF83-37D111D59D82Q36947714-8DB5E95C-EF23-4F9E-8C20-B1AAF6B210B3Q37969781-D6E10787-1A77-4678-ADA7-875E29671377Q38156452-9E334C3A-C79E-4F73-89F3-F151847AE418Q38256368-ECCD7F27-8CF5-4D0B-9575-61D31E11DADCQ38656979-C3A7170A-3549-487A-B9D6-205C59AB7AB7Q39018550-8012DEF4-7984-47EC-B10F-169228769666Q39826773-9BC2B21E-E10E-451A-B393-37DB9A8C5E4CQ40097312-79CE5E1A-3A34-413D-83AB-B4D56C19CF85Q42947243-06E88EBF-63FA-42AE-87B8-4EBABC7F04F8Q43536157-51F84ED2-E0A0-42E2-A5DC-CB79B4AEF71EQ46871860-D1A37321-5D7B-473D-B1BC-AB230254CD54Q56760512-A1579908-8489-4DB1-9833-23EE7D775DB4
P2860
Human carbonyl reduction pathways and a strategy for their study in vitro.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Human carbonyl reduction pathways and a strategy for their study in vitro.
@ast
Human carbonyl reduction pathways and a strategy for their study in vitro.
@en
type
label
Human carbonyl reduction pathways and a strategy for their study in vitro.
@ast
Human carbonyl reduction pathways and a strategy for their study in vitro.
@en
prefLabel
Human carbonyl reduction pathways and a strategy for their study in vitro.
@ast
Human carbonyl reduction pathways and a strategy for their study in vitro.
@en
P2860
P356
P1476
Human carbonyl reduction pathways and a strategy for their study in vitro.
@en
P2093
John S Walsh
M Jane Cox Rosemond
P2860
P304
P356
10.1081/DMR-120034154
P407
P577
2004-05-01T00:00:00Z